Lavaca Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-3,400
Closed -$1.1M – 156
2022
Q2
$1.1M Sell
3,400
-1,500
-31% -$450K 0.16% 66
2022
Q1
$1.4M Buy
4,900
+200
+4% +$51.5K 0.15% 71
2021
Q4
$1.3M Sell
4,700
-200
-4% -$50.7K 0.17% 67
2021
Q3
$1.13M Sell
4,900
-300
-6% -$74K 0.11% 74
2021
Q2
$1.19M Buy
+5,200
New +$1.04M 0.12% 68

Other funds holding LLY

Lavaca Capital's LLY Position: Q2 2026 in Review

Lavaca Capital increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $102K and bringing the position to 486 shares worth $583K. The position accounts for 0.06% of the portfolio, ranked #74.

Lavaca Capital first reported a position in LLY in Q4 2018 and has held it in 26 quarters since. The position peaked at $3.71M in Q4 2021. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lavaca Capital held 486 shares of Eli Lilly worth $583K as of Q2 2026.
  • Lavaca Capital bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.06% of Lavaca Capital's portfolio in Q2 2026, its #74 holding.
  • Lavaca Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 26 quarters since.
  • Lavaca Capital's Eli Lilly position peaked at $3.71M in Q4 2021.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.